advances in efgr-mutant nsclc treatment
Published 1 year ago • 68 plays • Length 4:37Download video MP4
Download video MP3
Similar videos
-
1:05
advances in managing krasg12c- and egfr-mutated nsclc
-
1:26
the challenge of treatment resistance in patients with advanced egfr-mutated nsclc
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
2:03
amivantamab and lazertinib in treatment-naïve egfr-mutant nsclc
-
0:43
developments in the management of egfr-mutated nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
1:04
molecular testing in egfr mutant driven nsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
58:47
15 years of advances in egfr mutant lung cancer
-
2:21
osimertinib ipilimumab in egfr-mutated nsclc
-
2:01
checkmate-722: investigating the addition of immunotherapy to chemotherapy in egfr-mutant nsclc
-
2:06
continued use of osimertinib reduces cns metastasis in egfr mutant lung cancer
-
2:28
amivantamab in patients with egfr ex20ins-mutated nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
1:44
dr. oxnard on delaying second-line treatment in egfr-mutant lung cancer
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
2:35
recent advancements in lung cancer treatment
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
2:36
atezolizumab with erlotinib in combination treatment for egfr mutant nsclc